Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

Also called NCT07307989

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07307989
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07307989. Randomized; single masking; primary purpose treatment. Start 2025-08-01 (actual); primary completion 2029-07-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
Condition
Hypercholesteremia
Intervention (Drug)
statin + ezetimibe
Intervention (Drug)
Statin monotherapy (rosuvastatin or atorvastatin)
Lead sponsor
Chang Gung Memorial Hospital (class: other)
Collaborator
Chang Gung University (class: other)

Record details

Record id
cardio:ct-nct07307989
Content hash
b61e762663e7c223ff48e154695008608925ece746cb7629ed2957066d3d717b